Product image of Glucos Fresenius Kabi (Glucose) supplied by GNH India

Glucos Fresenius Kabi

Active Ingredient:
Glucose
Origin:
EU

Glucos Fresenius Kabi (Glucose)

Glucos Fresenius Kabi is an intravenous solution containing glucose as the active ingredient. It is supplied in a parenteral nutrition formulation without a disclosed strength, intended for intravenous administration. The product is marketed in the European Union and classified as a prescription (Rx) excipient used to provide carbohydrate energy in clinical settings.

Manufacturer / TM Owner

Fresenius Kabi Ab

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Glucos Fresenius Kabi is employed when a rapid source of carbohydrate is required intravenously. It supports patients who cannot receive oral nutrition and helps maintain fluid and electrolyte balance.

  • Treatment of hypoglycemia in acute care settings
  • Component of total parenteral nutrition (TPN) regimens
  • Fluid and electrolyte replacement during surgery or trauma
  • Support for critically ill patients requiring energy supplementation
  • Nutritional support for neonates and infants when enteral feeding is not possible

Side Effects

Side effects of intravenous glucose solutions can vary in frequency and severity.

Common

  • Hyperglycemia (elevated blood glucose levels)
  • Local irritation or phlebitis at the infusion site
  • Electrolyte disturbances, such as hyponatremia
  • Fluid overload, especially in patients with cardiac or renal impairment

Serious

  • Severe hyperglycemia leading to diabetic ketoacidosis
  • Allergic reaction or anaphylaxis (rare)
  • Severe electrolyte imbalance causing cardiac arrhythmia
  • Pulmonary edema due to rapid volume expansion

Precautions & Warnings

Clinicians should assess patient-specific factors before administering Glucos Fresenius Kabi. Proper monitoring and dosage adjustments are essential to minimize risks.

  • Verify blood glucose levels prior to infusion and monitor during therapy
  • Adjust infusion rate in patients with renal or cardiac failure to avoid fluid overload
  • Use caution in diabetic patients or those with impaired glucose tolerance
  • Ensure compatibility with other intravenous solutions to prevent precipitation
  • Observe for signs of infection at the catheter site
  • Document any adverse reactions promptly

Avoid Interactions

Glucose solutions may interact with other medications or clinical conditions, influencing safety and efficacy.

Avoid

  • Co-administration with high-dose insulin without appropriate monitoring, which can cause severe hypoglycemia
  • Simultaneous infusion of calcium-containing solutions that may precipitate with phosphate

Use with caution

  • Concurrent use of diuretics, which may exacerbate electrolyte shifts
  • Administration alongside beta‑adrenergic agonists that can increase blood glucose levels
  • Use in patients receiving corticosteroids, which may raise glucose concentrations
  • Combination with other hypertonic solutions, requiring careful volume management

Frequently Asked Questions

Glucos Fresenius Kabi provides an intravenous source of glucose to supply carbohydrate energy for patients who cannot eat or absorb nutrients orally.

It is used for treating hypoglycemia, as part of total parenteral nutrition, and for fluid and electrolyte replacement during surgery, trauma, or critical illness.

The product is administered intravenously, typically through a peripheral or central venous catheter, according to the prescribed infusion rate.

Blood glucose levels, electrolytes, and fluid balance should be regularly monitored to detect hyperglycemia, electrolyte disturbances, or fluid overload.

Yes, but it requires careful dosing and frequent glucose monitoring to avoid excessive hyperglycemia.

Common side effects include hyperglycemia, local irritation or phlebitis at the infusion site, electrolyte imbalances, and potential fluid overload.

Serious reactions can include severe hyperglycemia leading to ketoacidosis, allergic reactions such as anaphylaxis, significant electrolyte disturbances causing arrhythmias, and pulmonary edema.

The solution should be avoided in patients with known hypersensitivity to glucose solutions and used with caution in those with uncontrolled diabetes, severe renal or cardiac failure.

When given with insulin, glucose infusion can cause rapid changes in blood sugar; insulin doses may need adjustment and glucose levels must be closely monitored.

Compatibility with calcium or phosphate-containing solutions should be checked to prevent precipitation, and total fluid volume should be calculated to avoid overload.

Yes, it can be part of neonatal parenteral nutrition regimens when enteral feeding is not possible, under strict medical supervision.

The solution should be stored according to the manufacturer’s instructions, typically at controlled room temperature, protected from light, and used before the expiration date.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Glucose

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT